Hoth Therapeutics, Inc. (HOTH) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
1177 Avenue of the Americas
New York, NY 10036
United States of America (the)
Phone
646 756 2997
Sector
Healthcare
Industry
Biotechnology
Employees
6
First IPO Date
February 15, 2019
| Name | Title | Pay | Year Born |
| Robb Knie | Founder, President, Chief Executive Officer & Chairman | 832,710 | 1969 |
| David S. Briones | Chief Financial Officer | 0 | 1976 |
| Hayley Springer | Executive Vice President of Operations | 0 | N/A |
Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in New York, NY.